Venn Diagram MedTech Success – Aligning Product and Business Strategy

MedDevice by Design with Mark Drlik and Ariana Wilson
Resources

Venn Diagram MedTech Success – Aligning Product and Business Strategy

YouTube video thumbnail

In this episode of MedDevice by Design, we explore how the Venn Diagram MedTech Success model helps early-stage companies align product design with commercial strategy. Mark Drlik and Ariana Wilson share how this triple Venn framework, focusing on feasibility, viability, and desirability, can diagnose the strengths and weaknesses of a MedTech product or startup.

What Is the Venn Diagram MedTech Success Model?

The Venn Diagram MedTech Success framework consists of three intersecting pillars:

  • Feasibility: Can we build it? Do we have the technical and engineering capability?
  • Viability: Can we sell it? Will it generate economic value in a competitive market?
  • Desirability: Will users and payers want it? Does it meet clinical and user needs?

Mark emphasizes that while most teams focus heavily on feasibility, overlooking the business and market context can derail an otherwise brilliant product.

Applying the Venn Diagram to Real-World MedTech Devices

Mark uses intravascular lithotripsy—a device designed to break up calcified plaque in arteries—as a real-world example. This innovation checked all three boxes:

  • A strong business strategy and regulatory plan (viability)
  • A differentiated product that improved safety and effectiveness (desirability)
  • A feasible, proven technical path with clinical precedent (feasibility)

By mapping success factors in each area, teams can assess risk early, validate commercial potential, and focus their development investment where it matters most.

Why This Matters in Early-Stage MedTech

The Venn Diagram MedTech Success model is especially useful for startups navigating limited budgets and uncertain markets. It helps founders:

  • Prepare for investment pitches
  • Avoid over-engineering a product no one wants
  • Prioritize features that drive adoption and reimbursement

Whether you’re aiming for acquisition or full commercialization, this framework offers a repeatable, cross-functional approach to building successful medical technologies.

96-well lab plates with a red arrow pointing to a green recycling symbol, representing lab plastic recycling for sustainability in medtech.

Nick Allan and Nigel Syrotuck explore the massive volume of single-use plastic in labs and discuss a new company working to close the loop through a circular economy approach.

Nick Allan and Nigel Syrotuck smiling during a Bio Break Book Club episode. Nigel holds the book Why We Sleep by Matthew Walker.

Nick Allan and Nigel Syrotuck share what they have been reading lately. From exploring the science of sleep to diving into change management, their picks show how books can spark insight both inside and outside the lab.

“Hands holding books under the text ‘End-of-Summer Reads,’ highlighting FDA regulatory books and PCR memoirs.

Nick Allan and Nigel Syrotuck share their end-of-summer reading list, featuring FDA regulatory books and PCR memoirs. From navigating regulatory hurdles to celebrating groundbreaking discoveries, their choices show how science reading can be both educational and entertaining.

Project manager using AI project management dashboard on laptop with holographic interface for medical device development.

Project managers are on the front lines of rising complexity in medical device development. They sit at the intersection of vendor timelines, regulatory constraints, and engineering realities.